You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雲南白藥(000538.SZ)擬向金健橋增資6419萬元並受讓其12.78%股權
格隆匯 12-10 20:53

格隆匯12月10日丨雲南白藥(000538.SZ)公佈,為逐步構建公司醫療器械產業平台,雲南白藥擬向安徽金健橋醫療科技有限公司(以下簡稱“金健橋”)增資並受讓部分股權。交易完成後,短期內繼續放大目標公司現有業務銷量;同時與公司器械業務板塊整合以承接公司器械項目的研發、生產及銷售業務。

本次交易方案分為增資及股權轉讓兩個階段。暨雲南白藥擬對金健橋增資6419萬元,增資後雲南白藥持有金健橋57.22%的股權,金健橋註冊資本變更為2597.08萬元。本次增資完成後,雲南白藥擬以1341萬元對價受讓部分股東持有的金健橋合計12.78%股權。

本次轉讓的具體情況為:合肥科訊睿見科技有限公司(以下簡稱“科訊睿見”)擬將其持有的金健橋9.74%股權作價1,000.00萬元轉讓給雲南白藥、李鋒擬將其持有的金健橋1.61%股權作價180.70萬元轉讓給雲南白藥、曹亮明擬將其持有的金健橋1.40%股權作價156.80萬元轉讓給雲南白藥、李楊擬將其持有的金健橋0.03%股權作價3.50萬元轉讓給雲南白藥。轉讓完成後,公司將持有金健橋70%的股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account